Literature DB >> 167093

The pituitary-adrenal system of the genetically obese (ob/ob) mouse.

J A Edwardson, C A Hough.   

Abstract

Adult genetically obese (ob/ob) mice which are characterized by adrenal hypertrophy and increased secretion of corticosteroids have considerably increased levels of ACTH in the pituitary gland. At 5 weeks of age there is no difference in the pituitary ACTH content of lean and obese animals and dietary restriction, sufficient to maintain body weight at normal values, reduces the pituitary ACTH content of adult obese mice from 14 times the level found in lean litter-mate controls to almost normal values. Using an in-vitro perifusion system, the release of ACTH from isolated pituitary glands was studied. Pituitaries from lean and obese mice responded similarly to stimulation with a crude extract of hypothalamic tissue containing coticotrophin releasing factor (CRF). The CRF content of the hypothalamus in both groups appears to be similar. In contrast with the high pituitary content, plasma values for ACTH in unstressed obese mice are not increased. The results are discussed in relation to other evidence for a hypothalamic disorder in ob/ob mice.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 167093     DOI: 10.1677/joe.0.0650099

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  16 in total

1.  The HPA axis modulates the CNS melanocortin control of liver triacylglyceride metabolism.

Authors:  Petra Wiedmer; Nilika Chaudhary; Michaela Rath; Chun-Xia Yi; Gayathri Ananthakrishnan; Rubén Nogueiras; Eva K Wirth; Henriette Kirchner; Ulrich Schweizer; Wenke Jonas; Christelle Veyrat-Durebex; Francoise Rohner-Jeanrenaud; Annette Schürmann; Hans-Georg Joost; Matthias H Tschöp; Diego Perez-Tilve
Journal:  Physiol Behav       Date:  2011-10-28

2.  Increase in pituitary melanocyte-stimulating hormone activity of genetically obese (ob/ob) mice.

Authors:  M H Peaslee; B Moisset; H Shibuya; C B Pert
Journal:  Experientia       Date:  1980-01-15

Review 3.  Neuroendocrine effects of leptin.

Authors:  F P Pralong; R C Gaillard
Journal:  Pituitary       Date:  2001 Jan-Apr       Impact factor: 4.107

4.  Neuropeptide Y levels are associated with nutritional status and cardiovascular events in adults with chronic kidney disease.

Authors:  L Lu; Y-C Zou; M Wang; Y-F Huang; D-X Chen; L-B Wei
Journal:  Eur J Clin Nutr       Date:  2015-04-29       Impact factor: 4.016

Review 5.  Biological insights through genomics: mouse to man.

Authors:  E M Rubin; G S Barsh
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

6.  Naloxone and weight reduction: an exercise in introspection.

Authors:  T B Schwartz
Journal:  Trans Am Clin Climatol Assoc       Date:  1981

7.  Actions of alpha-, beta- and ganglion-blockade on the pressor responses to angiotensins I and II in the conscious rabbit [proceedings].

Authors:  K A Munday; A R Noble; B P Rowe
Journal:  J Physiol       Date:  1978-02       Impact factor: 5.182

8.  Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice.

Authors:  P R Flatt; C J Bailey
Journal:  Diabetologia       Date:  1981-05       Impact factor: 10.122

9.  EVALUATION OF PLASMA SUBSTANCE P AND BETA-ENDORPHIN LEVELS IN CHILDREN WITH PRADER-WILLI SYNDROME.

Authors:  M G Butler; T A Nelson; D J Driscoll; A M Manzardo
Journal:  J Rare Disord       Date:  2015-09

10.  Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2-/- lipodystrophic mice independent of hepatocyte leptin receptors.

Authors:  Víctor A Cortés; Kelly M Cautivo; Shunxing Rong; Abhimanyu Garg; Jay D Horton; Anil K Agarwal
Journal:  J Lipid Res       Date:  2013-11-30       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.